This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Donato Greco, MD; Stefania Salinaso, DBiol; Paola Mastrantonio, DBiol, PhD; Progetto Pertosse
Istituto Superiore di Sanitá Rome, Italy

JAMA. 1994;272(24):1898-1899.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—We would like to comment on the Medical News & Perspectives report in THE JOURNAL¹ on the need for a national ethics advisory board in the United States. It is unclear to us why the clinical trial of pertussis vaccines in Italy (Progetto Pertosse) is automatically assumed to have inadequately protected the rights of human subjects. The report of the meeting of the Congressional Biomedical Research Caucus infers that conclusions of impropriety have been reached or there is wide dissenting opinion in Italy on the conduct of this project. As such, the scientific readership of JAMA has not had the opportunity to consider other views on the project from researchers of the Istituto Superiore di Sanitá (ISS) (the technical and scientific body of the Italian Health System) who conducted the project or members of ethics, pharmacoepidemiologic, or pediatric groups in Italy.

While there is no doubt . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?